Clinical Trial Update: Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy, safety, and tolerability of once-daily and twice-daily AZD1981 in asthma patients has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD1981

Snippet

Sponsor: AstraZeneca | Conditions: Asthma Patients | Phase 2 | Status: COMPLETED | Results posted: 2013-09-10